Medtronic unveils post-merger management structure

October 30, 2014 by Val Kennedy

Medtronic CEO Omar Ishrak unveils the plan for the medical device giant’s management structure after it closes its mega-merger with Covidien early next year.

Medtronic (NYSE:MDT) CEO Omar Ishrak today unveiled what the medical device giant’s management structure will look like after it closes its mega-merger with Covidien (NYSE:COV) early next year.

According to an employee presentation filed with the SEC, the ‘new’ Medtronic will be comprised of 4 major business segments, headed by Medtronic’s 3 existing group presidents, plus Covidien group president Bryan Hanson.

The Covidien group is slated to oversee all of that company’s current businesses except 2: Covidien’s peripheral vascular business will be merged into Medtronic’s aortic and peripheral unit, while Covidien’s neurovascular business will function as a unit of Medtronic’s restorative therapies group.



Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *